Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Trial With TriPRIL CAR T Cells for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

NCT05020444 is registered in ClinicalTrials.gov with Marcela V. Maus, M.D.,Ph.D. as lead sponsor.

NCT NCT05020444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05020444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Trial With TriPRIL CAR T Cells for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Lead sponsor
Marcela V. Maus, M.D.,Ph.D.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 5, 2021
Completion date
February 24, 2028
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, multiple myeloma in relapse, refractory multiple myeloma